Dry Eye
Showing 51 - 75 of >10,000
Sjogren's Syndrome, Dry Eye Trial (Varenicline Nasal Spray)
Not yet recruiting
- Sjogren's Syndrome
- Dry Eye
- Varenicline Nasal Spray
- (no location specified)
Jan 26, 2023
Allergic Conjunctivitis, Dry Eye, Dry Eye Disease Trial in Catanzaro (HPMC-HA eyedrops)
Completed
- Allergic Conjunctivitis
- +2 more
- HPMC-HA eyedrops
-
Catanzaro, CZ, ItalyAzienda Ospedaliera Policlinico Mater Domini - Università Magna
Apr 13, 2023
Dry Eye Trial in Fort Worth (Propylene glycol solution/drops)
Not yet recruiting
- Dry Eye
- Propylene glycol solution/drops
-
Fort Worth, TexasAlcon Call Center for Trial Locations
Jun 27, 2023
Dry Eye Trial in Shenyang (Diquafosol tetrasodium, Heated eye mask)
Not yet recruiting
- Dry Eye
- Diquafosol tetrasodium
- Heated eye mask
-
Shenyang, Liaoning, ChinaHe Eye Hospital
Jan 31, 2023
Dry Eye Syndromes Trial in Kowloon, Shatin (TCM ultrasonic atomization treatment with herbal Compound Decoction (CD), TCM
Not yet recruiting
- Dry Eye Syndromes
- TCM ultrasonic atomization treatment with herbal Compound Decoction (CD)
- +4 more
-
Kowloon, Hong Kong
- +3 more
Oct 13, 2023
Dry Eye Disease Trial (IPRL device, pharmacological therapy & Eyelid hygiene)
Not yet recruiting
- Dry Eye Disease
- IPRL device
- pharmacological therapy & Eyelid hygiene
- (no location specified)
Oct 30, 2022
Dry Eye Disease Trial (BRM421 Ophthalmic Solution, Vehicle)
Not yet recruiting
- Dry Eye Disease
- BRM421 Ophthalmic Solution
- Vehicle
- (no location specified)
Jan 13, 2023
Dry Eye Trial in Waterloo (Hydra-PEG, Uncoated)
Active, not recruiting
- Dry Eye
- Hydra-PEG
- Uncoated
-
Waterloo, Ontario, CanadaSchool of Optometry & Vision Science, University of Waterloo
Jan 26, 2023
Dry Eye Syndromes, Eye Diseases Trial in Memphis (OTX-DED, Controlled Insertion, Collagen Punctal Plug)
Not yet recruiting
- Dry Eye Syndromes
- Eye Diseases
- OTX-DED
- +2 more
-
Memphis, TennesseeOcular Therapeutix
Apr 12, 2023
Dry Eye Disease, Dry Eye, Kerato Conjunctivitis Sicca Trial in Catania (Cross-linked hyaluronic acid eye drops)
Recruiting
- Dry Eye Disease
- +3 more
- Cross-linked hyaluronic acid eye drops
-
Catania, CT, ItalyAzienda Ospedaliero-Universitaria Policlinico "G.Rodolico - San
Apr 11, 2023
Ocular Surface of Visual Display Users With and Without Dry Eye
Completed
- Dry Eye Disease
- no intervention
-
Beijing, ChinaPeking University Third Hospital
Nov 20, 2022
Different Subtypes of Primary Sjogren Syndrome Related Dry Eye
Recruiting
- Dry Eye
- Cyclosporine
-
Beijing, ChinaPeking University Third Hospital
Oct 30, 2022
Patients Developing Chronic Dry Eye After Refractive Surgery
Not yet recruiting
- Dry Eye
- FS-LASIK
-
Beijing, Beijing, ChinaPeking University Third Hospital
Oct 29, 2022
Dry Eye Disease Trial in Waterloo (0.09% cyclosporine A ophthalmic solution)
Recruiting
- Dry Eye Disease
- 0.09% cyclosporine A ophthalmic solution
-
Waterloo, Ontario, CanadaUniversity of Waterloo
Jul 13, 2023
Dry Eye Disease Trial in Andover (Reproxalap Ophthalmic Solution (0.25%), Placebo Comparator)
Completed
- Dry Eye Disease
- Reproxalap Ophthalmic Solution (0.25%)
- Placebo Comparator
-
Andover, MassachusettsAndover Eye Associates
Jan 24, 2023
Dry Eye Trial in Fort Worth (Polyethylene glycol 400 and propylene glycol solution/drops)
Not yet recruiting
- Dry Eye
- Polyethylene glycol 400 and propylene glycol solution/drops
-
Fort Worth, TexasAlcon Call Center for Trial Locations
Jun 5, 2023
Dry Eye Disease Trial in Hanzhou (Pluripotent Stem Cell-derived Mesenchymal Stem Cell Exosome (PSC-MSC-Exo) Eye Drops)
Not yet recruiting
- Dry Eye Disease
- Pluripotent Stem Cell-derived Mesenchymal Stem Cell Exosome (PSC-MSC-Exo) Eye Drops
-
Hanzhou, Zhejiang, China2nd Affiliated Hospital, School of Medicine, Zhejiang University
Feb 21, 2023
Dry Eye Syndrome, Sjogren's Syndrome, Xerophthalmia Trial in Taipei (Chinese herbal tea VGH-DESJS-1)
Not yet recruiting
- Dry Eye Syndrome
- +2 more
- Chinese herbal tea VGH-DESJS-1
-
Taipei, TaiwanChing-Mao Chang
Dec 19, 2022
Dry Eye Trial in Mississauga (Reproxalap Ophthalmic Solution (0.25%), Xiidra® (5% lifitegrast ophthalmic solution))
Completed
- Dry Eye
- Reproxalap Ophthalmic Solution (0.25%)
- Xiidra® (5% lifitegrast ophthalmic solution)
-
Mississauga, Ontario, CanadaCliantha Research
Sep 26, 2022
Dry Eye Syndrome Trial in Wien (rhNGF 20 µg/mL, rhNGF 4 µg/mL)
Completed
- Dry Eye Syndrome
- rhNGF 20 µg/mL
- rhNGF 4 µg/mL
-
Wien, AustriaDepartment of Clinical Pharmacology
Dec 14, 2022
Dry Eye Disease Trial in Memphis (Naltrexone, Placebos)
Ocular Dryness in Patients Previously Diagnosed With Dry Eye
Recruiting
- Dryness
- +2 more
- Dry eye device
-
Giza, Egypt
- +1 more
Oct 25, 2022